Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas - CNBC
Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas CNBC
Eli Lilly Company News
Eli Lilly issues data sharing ultimatum to 340B hospitals - Healthcare Dive
Eli Lilly issues data sharing ultimatum to 340B hospitals Healthcare Dive
Eli Lilly and Company’s (LLY) Foundayo and Zepbound Set To Be Covered for Millions of Americans - Yahoo Finance
Eli Lilly and Company’s (LLY) Foundayo and Zepbound Set To Be Covered for Millions of Americans Yahoo Finance
Eli Lilly, Ascidian Sign $1.9 Billion Kidney-Disease Treatment Deal - WSJ
Eli Lilly, Ascidian Sign $1.9 Billion Kidney-Disease Treatment Deal WSJ
Eli Lilly and Boehringer Cancel Investments - CHEManager
Eli Lilly and Boehringer Cancel Investments CHEManager
Why is Eli Lilly stock surging today? - Investing.com
Why is Eli Lilly stock surging today? Investing.com
Eli Lilly and Co (LLY) Stock Price, Trades & News - GuruFocus
Eli Lilly and Co (LLY) Stock Price, Trades & News GuruFocus
CVS Health Just Announced Fantastic News to Eli Lilly Stock Investors - The Motley Fool
CVS Health Just Announced Fantastic News to Eli Lilly Stock Investors The Motley Fool
Eli Lilly moves to cut off 340B pricing from noncompliant hospitals - BenefitsPRO
Eli Lilly moves to cut off 340B pricing from noncompliant hospitals BenefitsPRO
Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial | Eli Lilly and Company - investor.lilly.com
Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial | Eli Lilly and Company investor.lilly.com
CVS Health Just Announced Fantastic News to Eli Lilly Stock Investors - The Globe and Mail
CVS Health Just Announced Fantastic News to Eli Lilly Stock Investors The Globe and Mail
Eli Lilly and Jumps 5.5% Amid Sector-Wide Rally - AlphaStreet
Eli Lilly and Jumps 5.5% Amid Sector-Wide Rally AlphaStreet
Eli Lilly and Co Stock (LLY) Moved Up by 3.15% on Jun 5: Facts Behind the Movement - TradingKey
Eli Lilly and Co Stock (LLY) Moved Up by 3.15% on Jun 5: Facts Behind the Movement TradingKey
Can Eli Lilly's 2026 Acquisition Spree Diversify Growth Beyond GLP-1s? - TradingView
Can Eli Lilly's 2026 Acquisition Spree Diversify Growth Beyond GLP-1s? TradingView
People lost up to 85 pounds on Lilly’s experimental weight loss drug, company says - NBC News
People lost up to 85 pounds on Lilly’s experimental weight loss drug, company says NBC News
Eli Lilly and Co Stock (LLY) Moved Up by 3.56% on Jun 4: What Signal Does It Send? - TradingKey
Eli Lilly and Co Stock (LLY) Moved Up by 3.56% on Jun 4: What Signal Does It Send? TradingKey
Healthy Returns: Eli Lilly makes a new push into vaccines — here’s what to know - CNBC
Healthy Returns: Eli Lilly makes a new push into vaccines — here’s what to know CNBC
Eli Lilly and Co (LLY) Shares Surge 4.3% -- What GF Score of 98 Tells Investors - GuruFocus
Eli Lilly and Co (LLY) Shares Surge 4.3% -- What GF Score of 98 Tells Investors GuruFocus
FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions - investor.lilly.com
FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions investor.lilly.com
Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes - investor.lilly.com
Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes investor.lilly.com
A Next-Generation Drug Causes Dramatic Weight Loss, Eli Lilly Says - Time Magazine
A Next-Generation Drug Causes Dramatic Weight Loss, Eli Lilly Says Time Magazine
Trump Bought Stock in Drugmaker as His Government Boosted Its Obesity Drugs - KFF Health News
Trump Bought Stock in Drugmaker as His Government Boosted Its Obesity Drugs KFF Health News
Lilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance - investor.lilly.com
Lilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance investor.lilly.com
Eli Lilly tops prominent rankings on pharma R&D performance - statnews.com
Eli Lilly tops prominent rankings on pharma R&D performance statnews.com
US pharma giant Eli Lilly is very unhappy with Germany; CEO calls its planned healthcare reform: Terrible - The Times of India
US pharma giant Eli Lilly is very unhappy with Germany; CEO calls its planned healthcare reform: Terrible The Times of India
An open letter from Eli Lilly and Company warning of potential patient safety risks associated with tirzepatide compounded with vitamin B12 - investor.lilly.com
An open letter from Eli Lilly and Company warning of potential patient safety risks associated with tirzepatide compounded with vitamin B12 investor.lilly.com
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders | Eli Lilly and Company - investor.lilly.com
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders | Eli Lilly and Company investor.lilly.com
Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans - investor.lilly.com
Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans investor.lilly.com
Lilly to acquire Orna Therapeutics to advance cell therapies | Eli Lilly and Company - investor.lilly.com
Lilly to acquire Orna Therapeutics to advance cell therapies | Eli Lilly and Company investor.lilly.com
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies | Eli Lilly and Company - investor.lilly.com
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies | Eli Lilly and Company investor.lilly.com
Eli Lilly shares bought on Trump’s behalf as his policies benefited drug firm - The Guardian
Eli Lilly shares bought on Trump’s behalf as his policies benefited drug firm The Guardian
Lilly commits additional $4.5 billion across Indiana manufacturing sites, opens first dedicated genetic medicine facility - PR Newswire
Lilly commits additional $4.5 billion across Indiana manufacturing sites, opens first dedicated genetic medicine facility PR Newswire
Eli Lilly and the ‘societal obligation’ of GLP-1s - statnews.com
Eli Lilly and the ‘societal obligation’ of GLP-1s statnews.com
NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery In the Age of AI | Eli Lilly and Company - investor.lilly.com
NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery In the Age of AI | Eli Lilly and Company investor.lilly.com
Eli Lilly Just Announced Fantastic News for Shareholders - The Motley Fool
Eli Lilly Just Announced Fantastic News for Shareholders The Motley Fool
Eli Lilly and Company announces additional $4.5 billion investment in 2 Lebanon sites - Fox 59
Eli Lilly and Company announces additional $4.5 billion investment in 2 Lebanon sites Fox 59
Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial | Eli Lilly and Company - investor.lilly.com
Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial | Eli Lilly and Company investor.lilly.com
Eli Lilly Stock: Next Stop $2,000? - The Motley Fool
Eli Lilly Stock: Next Stop $2,000? The Motley Fool
In honor of its 150th anniversary, Eli Lilly and Company commits to support community organizations aiming to provide 500,000 meals and cold storage for 150 food pantries - PR Newswire
In honor of its 150th anniversary, Eli Lilly and Company commits to support community organizations aiming to provide 500,000 meals and cold storage for 150 food pantries PR Newswire
Lilly data point to ‘maintenance’ strategies for GLP-1 weight loss - BioPharma Dive
Lilly data point to ‘maintenance’ strategies for GLP-1 weight loss BioPharma Dive